MedTrace Logo

Tadalafil Plus Tamsulosin for Male LUTS and ED

NCT04383093 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2020-05-11

No results posted yet for this study

Summary

Metabolic Syndrome (MetS) is a complex epidemic disorder with an impact on both lower urinary tract symptoms (LUTS) and erectile dysfunction (ED). Combination therapy of daily tadalafil and tamsulosin may provide relief to both diseases.

Aim of the present study is to assess the impact of combination therapy of Tadalafil 5mg plus Tamsulosin 0.4mg on LUTS and ED, according to presence vs. absence of Mets.

Conditions

  • Prostatic Hyperplasia, Benign
  • Lower Urinary Tract Symptoms
  • Erectile Dysfunction
  • Metabolic Syndrome

Interventions

DRUG

Tadalafil 5mg

Combination therapy of daily tadalafil plus tamsulosin

Sponsors & Collaborators

  • University of Florence

    lead OTHER

Principal Investigators

  • Mauro Gacci, MD · University of Florence

  • Arcangelo Sebastianelli, MD · University of Florence

  • Sergio Serni, MD · University of Florence

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2018-01-01
Completion
2018-01-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04383093 on ClinicalTrials.gov